Evoke plc (LON:EVOK - Get Free Report) was down 10% during trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analyst Weigh In
A number of brokerages have recently commented on EVOK. Berenberg Bank cut their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating for the company in a report on Wednesday, December 4th. Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 140 ($1.81) target price on shares of Evoke in a research report on Monday, December 16th.
View Our Latest Stock Analysis on EVOK
Evoke Price Performance
The firm has a market cap of £211.75 million, a P/E ratio of -1.19 and a beta of 0.84. The company's 50 day moving average is GBX 68.36 and its two-hundred day moving average is GBX 63.39.
Evoke (LON:EVOK - Get Free Report) last issued its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Research analysts predict that Evoke plc will post 12.7648305 EPS for the current year.
Insider Buying and Selling at Evoke
In other Evoke news, insider Andrea Gisle Joosen acquired 14,572 shares of the company's stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average price of GBX 70 ($0.90) per share, with a total value of £10,200.40 ($13,178.81). Company insiders own 27.00% of the company's stock.
Evoke Company Profile
(
Get Free Report)
Read More
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.